The HPV16 E6 oncoprotein and UVB irradiation inhibit the tumor suppressor TGFβ pathway in the epidermis of the K14E6 transgenic mouse

Experimental Dermatology
Marco Popoca-CuayaPatricio Gariglio

Abstract

High-risk human papillomaviruses (HR-HPVs) are the causative agents of cervical cancer, and they are also associated with a subset of head and neck squamous cell carcinomas. In addition, HPVs have also been postulated in the development of non-melanoma skin cancers (NMSC). In these cancers, the oncogene E6 is best known for its ability to inactivate the tumor suppressor p53 protein. Interestingly, in transgenic mice for HPV16 E6 (K14E6), it was reported that E6 alone induced epithelial hyperplasia and delay in differentiation in skin epidermis independently of p53 inactivation. Transforming growth factor β (TGFβ) is an important regulator of cell growth/differentiation and apoptosis, and this pathway is often lost during tumorigenesis. Ultraviolet radiation B (UVB) exposure activates diverse cellular responses, including DNA damage and apoptosis. In this study, we investigated whether the E6 oncogene alone or in combination with UVB dysregulate some components of the TGFβ pathway in the epidermis of K14E6 mice. We used 8-day-old K14E6 and non-transgenic mice irradiated and unirradiated with a single dose of UVB. We found that the E6 oncogene and UVB irradiation impair the TGFβ pathway in epidermis of K14E6 mice by downregulatio...Continue Reading

References

Dec 3, 1992·The New England Journal of Medicine·D S Preston, R S Stern
Jul 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·A B GlickS H Yuspa
Aug 8, 1996·Nature·K GalaktionovD Beach
Nov 30, 2000·Dermatology : International Journal for Clinical and Investigative Dermatology·T MeyerE Stockfleth
Jan 30, 2004·International Journal of Cancer. Journal International Du Cancer·Ethel-Michele de VilliersHans Scherübl
Aug 19, 2005·Molecular and Cellular Biology·Jenny S L HoSamuel Benchimol
Sep 17, 2005·Cancer Research·Sara J S SimonsonPaul F Lambert
Jun 15, 2007·Nature Reviews. Cancer·Rose BoutrosBernard Ducommun
Jul 21, 2007·Current Problems in Dermatology·Vered Molho-Pessach, Michal Lotem
Jan 4, 2008·Archives of Virology·Sandy S Tungteakkhun, Penelope J Duerksen-Hughes
Jan 17, 2008·Cell Cycle·Sébastien BrittonPatrick Calsou
Jan 23, 2008·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·J Seoane
Jul 30, 2008·Cell·Joan Massagué
Apr 21, 2009·Biochimica Et Biophysica Acta·A Lagunas-MartínezP Gariglio
Jun 23, 2009·Virus Research·Margaret E McLaughlin-Drubin, Karl Münger
Dec 19, 2009·Cytokine & Growth Factor Reviews·Brian Bierie, Harold L Moses
Jun 17, 2010·Photochemistry and Photobiology·Clio DessiniotiAlexander J Stratigos
Jul 16, 2010·The Journal of Investigative Dermatology·Mitchell F Denning
Oct 14, 2010·Cellular Signalling·Maozhen TianWilliam P Schiemann
Aug 2, 2011·Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology·Gerd P Pfeifer, Ahmad Besaratinia
May 23, 2012·Trends in Pharmacological Sciences·Henriett ButzAttila Patócs

❮ Previous
Next ❯

Citations

Nov 11, 2016·Diagnostic Pathology·Wenqi Chen, Jinhai Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis